Morning Research on Boston Scientific, Abbott Laboratories, Medtronic, Zimmer, and EnteroMedics

Tue Apr 2, 2013 8:01am EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130402:nPn4028705


LONDON,  April 2, 2013  /PRNewswire/ --

Medical appliances & equipment makers have been critical of President Obama's
Affordable Care Act (ACA). Under the healthcare reform, medical appliances &
equipment makers such as Boston Scientific Corporation (NYSE: BSX), Abbott
Laboratories (NYSE: ABT), Medtronic Inc. (NYSE: MDT), Zimmer Holdings Inc.
(NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM) are required to pay a 2.3%
excise tax on U.S. sales. The industry has been lobbying to repeal the 2.3% tax
on U.S. sales, saying that it would lead to higher costs and hamper research and
development activities. Medical appliances & equipment makers ended mostly lower
on Monday, tracking losses in the broad market. StockCall has posted free
technical research reports on BSX, ABT, MDT, ZMH, and ETRM and these can be
accessed by signing up at

http://www.stockcall.com/analysis

Shares of Boston Scientific Corporation touched a 52-week high of  $7.86 
yesterday, however, the stock failed to hold on to its gains. It closed 0.13%
lower at  $7.80  on above average volume of 29.66 million. Boston Scientific
shares have gained more than 4.80% in the last three trading sessions. The stock
has outperformed the broad market so far in 2013, gaining more than 36%. Its
MACD has just crossed above the signal line, which is a strong bullish signal.
Download the free report on BSX upon registration at

http://www.StockCall.com/BSX040213.pdf

Abbott Laboratories shares ended nearly flat in Monday's trading session. The
stock fell to an intra-day low of  $34.95  before paring most of its losses to
finish the day 0.03% lower at  $35.31  on volume of 6.03 million. The stock has
gained nearly 2.80% in the last three sessions. Abbott's shares recently broke
through  $35  resistance level, which is a strong bullish signal. The positive
trend is further confirmed by the stock's MACD chart. The company's shares are
also trading above their 50-day and 200-day moving averages. ABT technical
report can be accessed for free by signing up at

http://www.StockCall.com/ABT040213.pdf

Medtronic Inc.'s shares edged lower on Monday; however, the losses were limited.
The stock closed 0.34% lower at  $46.80  on volume of 2.81 million. The
company's shares are currently trading close to their 52-week high of  $47.40.
The stock has outperformed the broad market in 2013, gaining more than 14%. Its
shares are currently facing resistance at around  $47. The stock's MACD is
currently trading above the signal line and the zero-line, which is a bullish
signal. The free report on MDT can be downloaded by signing up now at

http://www.StockCall.com/MDT040213.pdf

Zimmer Holdings Inc.'s shares ended marginally lower yesterday. The stock ended
the day 0.12% lower at  $75.13  on volume of 693,613. Its shares are currently
hovering around their 52-week high of  $76.75. The stock saw a series of highs
last week, which is a bullish signal. The upbeat trend is further confirmed by
recent volume activity and the stock's MACD chart. Free report on ZMH can be
accessed by registering at

http://www.StockCall.com/ZMH040213.pdf

EnteroMedics Inc.'s shares rose sharply on Monday even as the broad market
struggled. The stock closed 1% higher at  $1.01  on volume of 776,418.
EnteroMedics' shares touched an intra-day high of  $1.04  yesterday. Despite the
gains, the stock is down nearly 1% in the last three trading sessions. Shares of
ETRM are currently trading well below their 50-day and 200-day moving averages.
Register with StockCall and download the research on ETRM for free at

http://www.StockCall.com/ETRM040213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the headlines. Sign up
today to talk to our financial analyst at

http://www.stockcall.com   

SOURCE  StockCall.com


Contact Person: William T. Knight, Email: info@stockcall.com, Contact Number:
+1(646)396-9857 (9:00 am EST - 01:30 pm EST)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.